EMPREENDIMENTOS PAGUE MENOS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.53 BRL | -1.17% |
|
-0.78% | -36.11% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 12.16B 2.37B | Sales 2025 * | 13.17B 2.56B | Capitalization | 1.46B 285M |
|---|---|---|---|---|---|
| Net income 2024 * | 81M 15.76M | Net income 2025 * | 139M 27.04M | EV / Sales 2024 * | 0.23 x |
| Net Debt 2024 * | 1.38B 269M | Net Debt 2025 * | 1.11B 216M | EV / Sales 2025 * | 0.2 x |
| P/E ratio 2024 * |
32.7
x | P/E ratio 2025 * |
11
x | Employees | 20,099 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.86% |
More Fundamentals
* Assessed data
More news
Latest transcript on Empreendimentos Pague Menos S.A.
More press releases
| 1 day | -1.17% | ||
| 1 week | -0.78% | ||
| 1 month | -7.66% | ||
| 3 months | -11.23% | ||
| 6 months | -20.94% | ||
| Current year | -36.11% |
1 week
2.48
2.66
1 month
2.402.74
Current year
2.403.96
1 year
2.404.75
3 years
2.4013.75
5 years
2.4013.75
10 years
2.4013.75
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 47 | 15-12-31 | |
Gianni Dias Gill
COO | Chief Operating Officer | - | 21-06-30 |
| Chief Tech/Sci/R&D Officer | - | 01-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 46 | - | |
| Director/Board Member | - | 81-12-31 | |
| Director/Board Member | 52 | 97-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +3.48% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 2.53 | -1.17% | 702 300 |
| 24-05-08 | 2.53 | -0.39% | 454,400 |
| 24-05-07 | 2.54 | -3.05% | 880,200 |
| 24-05-06 | 2.62 | 0.00% | 560,300 |
| 24-05-03 | 2.62 | +2.75% | 1,089,700 |
Delayed Quote Sao Paulo, May 09, 2024 at 04:06 pm EDT
More quotes
Empreendimentos Pague Menos SA is a Brazil-based company primarily engaged in the drug retail sector. Through a drugstore chain, the Company sells medicines, perfumes, personal care and household products, cosmetics, as well as grocery goods, among others. Additionally, It offers a range of financial services, such as bill collection and credit card issuing. The Company also operates a call center that provides information related to drugs usage.
Sector
Drug Retailers
Calendar
2024-08-04
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
2.53
BRL
Average target price
3.79
BRL
Spread / Average Target
+49.80%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.11% | 288M | |
| -33.93% | 14.86B | |
| -23.66% | 11.73B | |
| +16.46% | 6.3B | |
| -25.24% | 6.29B | |
| -9.39% | 6B | |
| -2.34% | 4.63B | |
| +60.00% | 4.57B | |
| -8.19% | 3.5B | |
| -6.41% | 3.04B |
- Stock Market
- Equities
- PGMN3 Stock